ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Diisopropylethylamine → 2-{4-[5-(2-Diethylamino-6-methyl-pyrimidin-4-yl)-[1,2,4]oxadiazol-3-yl]-phenyl}-ethanol

HRID 2069428
ノート
印刷プレビュー

反応式

HRID 2069428 の反応式
[CH2:1]([N:3]([CH2:14][CH3:15])[C:4]1[N:9]=[C:8]([C:10]([OH:12])=O)[CH:7]=[C:6]([CH3:13])[N:5]=1)[CH3:2].CCN(C(C)C)C(C)C.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.O[NH:48][C:49](=[NH:59])[C:50]1[CH:55]=[CH:54][C:53]([CH2:56][CH2:57][OH:58])=[CH:52][CH:51]=1>CN(C=O)C.CCOC(C)=O.O1CCOCC1>[CH2:14]([N:3]([CH2:1][CH3:2])[C:4]1[N:9]=[C:8]([C:10]2[O:12][N:59]=[C:49]([C:50]3[CH:55]=[CH:54][C:53]([CH2:56][CH2:57][OH:58])=[CH:52][CH:51]=3)[N:48]=2)[CH:7]=[C:6]([CH3:13])[N:5]=1)[CH3:15]
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 4

HCID 81531DiisopropylethylamineHCID 2733207O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborateHCID 242773182-(Diethylamino)-6-methylpyrimidine-4-carboxylic acidHCID 59604233CID 59604233

生成物 1

HCID 685054582-{4-[5-(2-Diethylamino-6-methyl-pyrimidin-4-yl)-[1,2,4]oxadiazol-3-yl]-phenyl}-ethanol収率 58.6%

試薬・触媒・溶媒

3
HCID 6228Dimethylformamide溶媒HCID 8857Ethyl Acetate溶媒HCID 312751,4-Dioxane溶媒

実験手順

To a suspension of 2-diethylamino-6-methylpyrimidine-4-carboxylic acid (1.31 g, 6.28 mmol) in DMF (20 mL) is added DIPEA (3.23 mL, 18.8 mmol) followed by TBTU (2.62 g, 8.17 mmol). The mixture is stirred at rt for 10 min before N-hydroxy-4-(2-hydroxy-ethyl)-benzamidine (1.24 g, 6.91 mmol) is added. After stirring for 1 h, the reaction mixture is diluted with EtOAc and the solution is washed with sat. aq. NaHCO3. The aq. phase is extracted with EtOAc and the combined org. extracts are dried over MgSO4, filtered and concentrated to give the crude hydroxyamidine ester intermediate (3.56 g). This material is dissolved in dioxane (50 mL) and the resulting solution is stirred at 85° C. for 16 h. The solvent is evaporated and the crude product is purified by CC (eluting with EtOAc/Heptane 1:4) to give 2-{4-[5-(2-diethylamino-6-methyl-pyrimidin-4-yl)-[1,2,4]oxadiazol-3-yl]-phenyl}-ethanol as a yellow solid (1.30 g); LC-MS: tR=1.07 min; [M+H]+=354.07. 1H NMR (CDCl3): δ 1.25 (t, J=7.0 Hz, 6H), 1.45 (m, 1H), 2.47 (s, 3H), 2.98 (t, J=6.5 Hz, 2H), 3.75 (q, J=7.0 Hz, 4H), 3.95 (m, 2H), 7.23 (s, 1H), 7.41 (d, J=7.8 Hz, 2H), 8.15 (d, J=7.5 Hz, 2H).

後処理

  1. additionis added
  2. washthe solution is washed with sat. aq. NaHCO3
  3. extractionThe aq. phase is extracted with EtOAc
  4. dry with materialextracts are dried over MgSO4
  5. filtrationfiltered
  6. concentrationconcentrated
  7. customto give the crude hydroxyamidine ester intermediate (3.56 g)
  8. stirringthe resulting solution is stirred at 85° C. for 16 h
  9. customThe solvent is evaporated
  10. customthe crude product is purified by CC (eluting with EtOAc/Heptane 1:4)

出典と根拠

ORDレコード
ord-719c55a66cdd4d2aae8c69664107398c
出典データセット
uspto-grants-2012_10
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08299086B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート